Compounded GLP-1s Are Not FDA-Approved Jorge Moreno, MD, an assistant professor and obesity medicine doctor at Yale Medicine in New Haven, Connecticut, says the findings highlight a broader concern that obesity specialists have about compounded versions of GLP-1 medications
YOUR FIRST 30 DAYS ON GLP-1: WHAT TO EAT AND HOW REDUCE SIDE EFFECTS, PROTECT MUSCLE, AND STAY ENERGIZED [EUBANK, C
Some patients experience mild queasiness
From GLP-1s, adrenal treatments, and acromegaly breakthroughs to obesity, diabetes, and cutting-edge research in reproductive medicine, 2025 was a banner year for endocrine research and researchers
Semaglutide nearly tripled the weight loss